Kim Ho Hyun, Park Eun Kyu, Seoung Jin Shick, Hur Young Hoe, Koh Yang Seok, Kim Jung Chul, Cho Chol Kyoon, Kim Hyun Jong
Division of Hepato-biliary-pancreatic Surgery, Department of Surgery, Chonnam National University Medical School, Gwangju, Korea.
J Korean Surg Soc. 2011 Jun;80(6):412-9. doi: 10.4174/jkss.2011.80.6.412. Epub 2011 Jun 9.
To analyze the outcomes of laparoscopic liver resection compared with open liver resection in patients with hepatocellular carcinoma (HCC).
Between July 2005 and December 2009, 26 consecutive patients with HCC underwent a pure laparoscopic liver resection, and data from this group (laparoscopic liver resection group, L-group) were compared with a retrospective control group of 29 patients who underwent open liver resection for HCC (open liver resection group, O-group) during the same period. The two groups were matched in terms of demographic data, tumor size, degree of liver cirrhosis, American Society of Anesthesiology score, type of resection, and tumor location.
Median operation time and the amount of intraoperative packed red blood cell transfusion in the L-group were 147.5 minutes and 0.35 units, respectively. The L-group revealed a shorter operation time (147.5 vs. 220.0 minutes, P = 0.031) than the O-group. No difference in perioperative morbidity or mortality rates was observed (3.8, 0 vs. 24.1%, 0%; P = 0.054, non-specific, respectively); the L-group was associated with a shorter hospital stay than the O-group (11.08 vs. 16.07 days, P = 0.034). After a mean follow-up of 23.9 months (range, 0.7 to 59.4 months), the 1-year disease-free survival rate was 84.6% in the L-group and 82.8% in the O-group (P = 0.673).
Laparoscopic liver resection for HCC is feasible and safe in selected patients and can produce good surgical results with a shorter postoperative hospital stay and similar outcomes in terms of perioperative morbidity, mortality, and disease-free survival than open resection.
分析肝细胞癌(HCC)患者行腹腔镜肝切除与开腹肝切除的疗效。
2005年7月至2009年12月,连续26例HCC患者接受单纯腹腔镜肝切除,将该组(腹腔镜肝切除组,L组)数据与同期29例行开腹肝切除治疗HCC的回顾性对照组(开腹肝切除组,O组)进行比较。两组在人口统计学数据、肿瘤大小、肝硬化程度、美国麻醉医师协会评分、切除类型及肿瘤位置方面相匹配。
L组中位手术时间及术中浓缩红细胞输注量分别为147.5分钟和0.35单位。L组手术时间短于O组(147.5对220.0分钟,P = 0.031)。围手术期发病率或死亡率无差异(分别为3.8%、0对24.1%、0%;P = 0.054,无特异性);L组住院时间短于O组(11.08对16.07天,P = 0.034)。平均随访23.9个月(范围0.7至59.4个月)后,L组1年无病生存率为84.6%,O组为82.8%(P = 0.673)。
对于部分选择的患者,腹腔镜肝切除治疗HCC是可行且安全的,与开腹切除相比,术后住院时间更短,围手术期发病率、死亡率及无病生存率相似,可取得良好的手术效果。